DJ Novavax Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 2.20% to $7.99 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.61% to 17,754.09 and the Dow Jones Industrial Average rising 1.65% to 41,488.19.
The stock's fall snapped a two-day winning streak.
Novavax Inc. closed 66.51% below its 52-week high of $23.86, which the company reached on June 6th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.11% to $162.81, Pfizer Inc. $(PFE)$ rose 0.47% to $25.72, and Merck & Co. Inc. $(MRK)$ fell 0.15% to $94.57.
Trading volume (5.0 M) eclipsed its 50-day average volume of 4.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 14, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 14, 2025 17:27 ET (21:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。